Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.4.0.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 163,766 $ 194,263
Short-term deposits 62,337 54,620
Accounts receivable, net of allowance for doubtful accounts of $- and $- (including $1,000 (2015: $2,000) due from related parties) 1 744
Other current assets and prepaid expenses (including current portion of clinical materials) 12,457 13,420
Total current assets 238,561 263,047
Restricted cash 4,413 4,508
Clinical materials 3,601 4,736
Property, plant and equipment, net 13,845 13,225
Intangibles, net 1,140 305
Total assets 261,560 285,821
Current liabilities    
Accounts payable 2,440 7,884
Accrued expenses and other accrued liabilities(including $229,000 (2015: $288,000) due to related parties) 5,321 7,518
Deferred revenue 12,077 12,487
Total current liabilities 19,838 27,889
Deferred revenue, less current portion 22,776 22,939
Total liabilities $ 42,614 $ 50,828
Contingencies and commitments - Note 7
Equity    
Common stock - Ordinary shares par value GBP 0.001, 574,711,900 authorized and 424,711,900 issued and outstanding (2015: 574,711,900 authorized and 424,711,900 issued and outstanding) $ 682 $ 682
Additional paid in capital 334,437 332,363
Accumulated other comprehensive loss (10,684) (8,139)
Accumulated deficit (105,489) (89,913)
Total equity 218,946 234,993
Total liabilities and stockholders' equity $ 261,560 $ 285,821